6-1611567-GGGCGGCGGC-GGGCGGC

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2

The NM_001453.3(FOXC1):​c.1139_1141delGCG​(p.Gly380del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000431 in 1,141,794 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. G380G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 24)
Exomes 𝑓: 0.00047 ( 2 hom. )

Consequence

FOXC1
NM_001453.3 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2B:1

Conservation

PhyloP100: 1.41

Publications

6 publications found
Variant links:
Genes affected
FOXC1 (HGNC:3800): (forkhead box C1) This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain. The specific function of this gene has not yet been determined; however, it has been shown to play a role in the regulation of embryonic and ocular development. Mutations in this gene cause various glaucoma phenotypes including primary congenital glaucoma, autosomal dominant iridogoniodysgenesis anomaly, and Axenfeld-Rieger anomaly. [provided by RefSeq, Jul 2008]
FOXC1 Gene-Disease associations (from GenCC):
  • anterior segment dysgenesis 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • Axenfeld-Rieger syndrome type 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • aniridia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Axenfeld anomaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Axenfeld-Rieger syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated aniridia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Peters anomaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Rieger anomaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00047 (468/995372) while in subpopulation MID AF = 0.000821 (2/2436). AF 95% confidence interval is 0.000438. There are 2 homozygotes in GnomAdExome4. There are 252 alleles in the male GnomAdExome4 subpopulation. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 24 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FOXC1NM_001453.3 linkc.1139_1141delGCG p.Gly380del disruptive_inframe_deletion Exon 1 of 1 ENST00000645831.2 NP_001444.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FOXC1ENST00000645831.2 linkc.1139_1141delGCG p.Gly380del disruptive_inframe_deletion Exon 1 of 1 NM_001453.3 ENSP00000493906.1

Frequencies

GnomAD3 genomes
AF:
0.000164
AC:
24
AN:
146422
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.000123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000206
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000258
Gnomad OTH
AF:
0.000497
GnomAD2 exomes
AF:
0.000590
AC:
8
AN:
13566
AF XY:
0.000676
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000698
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000613
Gnomad OTH exome
AF:
0.00260
GnomAD4 exome
AF:
0.000470
AC:
468
AN:
995372
Hom.:
2
AF XY:
0.000530
AC XY:
252
AN XY:
475402
show subpopulations
African (AFR)
AF:
0.000303
AC:
6
AN:
19790
American (AMR)
AF:
0.000520
AC:
3
AN:
5772
Ashkenazi Jewish (ASJ)
AF:
0.000267
AC:
3
AN:
11246
East Asian (EAS)
AF:
0.000450
AC:
5
AN:
11122
South Asian (SAS)
AF:
0.000265
AC:
6
AN:
22658
European-Finnish (FIN)
AF:
0.000598
AC:
9
AN:
15060
Middle Eastern (MID)
AF:
0.000821
AC:
2
AN:
2436
European-Non Finnish (NFE)
AF:
0.000476
AC:
414
AN:
870548
Other (OTH)
AF:
0.000544
AC:
20
AN:
36740
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.409
Heterozygous variant carriers
0
27
54
81
108
135
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000164
AC:
24
AN:
146422
Hom.:
0
Cov.:
24
AF XY:
0.000155
AC XY:
11
AN XY:
71196
show subpopulations
African (AFR)
AF:
0.000123
AC:
5
AN:
40756
American (AMR)
AF:
0.00
AC:
0
AN:
14744
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3388
East Asian (EAS)
AF:
0.000206
AC:
1
AN:
4852
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4796
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8696
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.000258
AC:
17
AN:
65960
Other (OTH)
AF:
0.000497
AC:
1
AN:
2012
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
107

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jun 01, 2018
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Axenfeld-Rieger syndrome type 3 Uncertain:1
Nov 25, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, c.1139_1141del, results in the deletion of 1 amino acid(s) of the FOXC1 protein (p.Gly380del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with FOXC1-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

FOXC1-related disorder Benign:1
Aug 16, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.4
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76840944; hg19: chr6-1611802; API